Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis

Currently, the indication for thrombolytic therapy using intravenous recombinant tissue plasminogen activator (rt-PA) is restricted strictly to patients with acute ischemic stroke within 4.5 h of onset. The effect of rt-PA declines over time; therefore, we need to minimize the time delay while gener...

Descripción completa

Detalles Bibliográficos
Autor principal: HIRANO, Teruyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663028/
https://www.ncbi.nlm.nih.gov/pubmed/26369875
http://dx.doi.org/10.2176/nmc.ra.2015-0111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663028/
https://www.ncbi.nlm.nih.gov/pubmed/26369875
http://dx.doi.org/10.2176/nmc.ra.2015-0111

Ejemplares similares